4//SEC Filing
Lagarde Michel 4
Accession 0000097745-25-000166
CIK 0000097745other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:47 PM ET
Size
8.6 KB
Accession
0000097745-25-000166
Insider Transaction Report
Form 4
Lagarde Michel
Executive Vice President & COO
Transactions
- Exercise/Conversion
Common Stock
2025-11-13$253.99/sh+4,638$1,178,006→ 28,117.909 total - Sale
Common Stock
2025-11-13$594.42/sh−4,638$2,756,920→ 23,479.909 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-13−4,638→ 0 totalExercise: $253.99Exp: 2026-02-26→ Common Stock (4,638 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $594.36 to $594.88, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023.
Documents
Issuer
THERMO FISHER SCIENTIFIC INC.
CIK 0000097745
Entity typeother
Related Parties
1- filerCIK 0001518973
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:47 PM ET
- Size
- 8.6 KB